Yellow Subretinal Lesions following Initiation of Antituberculosis Therapy in A Tubercular Choroidal Granuloma : A Sign of Paradoxical Worsening?

PURPOSE: To describe the presentation and management of atypical subretinal lesions following initiation of antitubercular therapy for a tubercular choroidal granuloma.

CASE REPORT: An 18-year-old female was diagnosed with choroidal granuloma and shallow exudative retinal detachment in the left eye. Biopsy from a cervical lymph node was positive for tuberculosis. She was treated with antitubercular therapy (ATT) and oral steroids. After one week of therapy exudative detachment increased markedly and discrete yellowish-white subretinal lesions appeared first in the inferior periphery, then temporally and later involved the macula leading to a drop in visual acuity. A diagnosis of paradoxical worsening was considered and she was managed with a higher dose of oral corticosteroids, intravitreal methotrexate and intravitreal ranibizumab. The granuloma healed and the subretinal lesions as well as exudative detachment gradually resolved with improvement in visual acuity.

CONCLUSION: Subretinal yellow-white lesions may develop as a paradoxical response to ATT.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:30

Enthalten in:

Ocular immunology and inflammation - 30(2022), 1 vom: 02. Jan., Seite 29-33

Sprache:

Englisch

Beteiligte Personen:

Arora, Atul [VerfasserIn]
Katoch, Deeksha [VerfasserIn]
Jain, Sahil [VerfasserIn]
Singh, Simar Rajan [VerfasserIn]
Gupta, Vishali [VerfasserIn]

Links:

Volltext

Themen:

ATT
Anti tubercular therapy
Antitubercular Agents
Case Reports
Choroidal granuloma
Journal Article
Ocular tuberculosis
Paradoxical worsening
Ranibizumab
SRHM
Subretinal deposits
ZL1R02VT79

Anmerkungen:

Date Completed 16.03.2022

Date Revised 22.04.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1080/09273948.2020.1780272

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM313584737